Allarae in Intellect distribution pact:
This article was originally published in Clinica
In a bid to increase its presence in the personal health management market, Allarae Healthcare has entered into a distribution agreement with Intellect, a personal health testing product specialist. The global, non-exclusive agreement sees Allarae distribute Intellect's testing kits and personal tracking software for home use. Allarae said that tests for strep, influenza, cholesterol and glucose levels are the first products to be shipped and sold, while tests for certain forms of cancer and hepatitis would be ready for market in 2008.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.